RNA-seq of butyrate micelle or control treated murine Ly6Chi CD11b+ myeloid cells
Ontology highlight
ABSTRACT: We aimed to study the impact of bacteria-derived metabolites in solid organ transplantation. The short-chain fatty acid butyrate was administered using a new drug-delivery method developed by Wang et al. (https://doi.org/10.1038/s41551-022-00972-5). This system is based on a micelle platform that carries and protects butyrate (ButM) from degradation in the upper gastrointestinal tract, to lower distal portions of the gut. Mice (adult B6 females) were treated for 21 days with ButM (100mg/mL) or 1x PBS. Splenic Ly6Chi CD11b+ monocytes were sorted for bulk RNAseq using the Takara SMART-Seq mRNA LP and Unique Dual Index kits. Libraries were sequenced using the Illumina NovaSeq 6000 platform.
INSTRUMENT(S): BD FACSAria III, Illumina NovaSeq 6000
ORGANISM(S): Mus musculus
SUBMITTER: Alexandra Cassano
PROVIDER: E-MTAB-13931 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA